Clinical bottom line
Pediatric acute bacterial sinusitis (ABS) is a common respiratory tract infection encountered in primary care. Current evidence supports a cautious, judicious approach to antibiotic use, emphasizing accurate diagnosis based on clinical criteria and reserving antibiotics for children with moderate to severe or persistent symptoms. Initial management often includes symptomatic care and watchful waiting, with antibiotics considered when clinical improvement does not occur or complications arise. This strategy aims to reduce unnecessary antibiotic exposure and resistance without compromising patient outcomes.
What the evidence shows
Acute bacterial sinusitis in children typically follows a viral upper respiratory infection and is diagnosed clinically by persistent symptoms beyond 10 days, severe onset with high fever and purulent nasal discharge, or worsening symptoms after initial improvement (Fang et al., 2015). The evidence indicates that many cases resolve spontaneously without antibiotics, and routine antibiotic prescribing does not significantly improve clinical outcomes in mild cases (Chiappini et al., 2014; Kronman et al., 2020).
Randomized controlled trials and systematic reviews have demonstrated that amoxicillin, the first-line antibiotic, provides modest benefit in symptom resolution compared to placebo but is not universally required (Fang et al., 2015; Gabbay et al., 2023). Some older studies found no significant improvement in acute maxillary sinusitis with amoxicillin, underscoring the importance of careful patient selection (Evidence-Based Dentistry, 1998; Evidence Based Medicine, 1997). The Italian Society of Preventive and Social Pediatrics consensus recommends antibiotics primarily for children with severe symptoms or those who fail to improve after 7–10 days of symptomatic treatment (Chiappini et al., 2014).
Symptomatic management, including analgesics and nasal saline irrigation, is effective and well tolerated (Fang et al., 2015). Overprescribing antibiotics contributes to antimicrobial resistance and adverse effects without clear benefit in mild or uncomplicated cases (Kronman et al., 2020). Clinical guidelines emphasize watchful waiting with close follow-up as a safe strategy in appropriate patients (Gabbay et al., 2023).
Caveats and uncertainty
Diagnosis of pediatric ABS remains challenging due to symptom overlap with viral upper respiratory infections and allergic rhinitis. There is no definitive diagnostic test in primary care, and imaging is generally not recommended unless complications are suspected (Fang et al., 2015). The clinical criteria for bacterial sinusitis are imperfect, potentially leading to both under- and overdiagnosis.
Most evidence derives from outpatient populations with mild to moderate disease; data on severe or complicated cases are limited. The optimal duration of antibiotic therapy is also not firmly established, with some guidelines supporting shorter courses but evidence still evolving (Chiappini et al., 2014).
Antibiotic stewardship must be balanced against the risk of rare but serious complications such as orbital cellulitis or intracranial extension. Individual patient factors, including age, comorbidities, and clinical course, should guide management decisions.
How this may change practice
Primary care clinicians should prioritize clinical diagnostic criteria and consider watchful waiting with symptomatic treatment for children presenting with suspected ABS who have mild or moderate symptoms. Antibiotics should be reserved for those with severe presentations, persistent symptoms beyond 10 days, or clinical deterioration.
Educating families about the natural course of ABS and the limited role of antibiotics may improve adherence to watchful waiting and reduce pressure for unnecessary prescriptions. Follow-up plans should be clearly communicated to identify children who require antibiotic initiation or specialist referral.
This evidence-based approach aligns with antimicrobial stewardship goals, aiming to reduce unnecessary antibiotic use while maintaining patient safety and quality of care.